Autologous mitochondrial microinjection; a strategy to improve the oocyte quality and subsequent reproductive outcome during aging
Abstract Along with the decline in oocyte quality, numerous defects such as mitochondrial insufficiency and the increase of mutation and deletion have been reported in oocyte mitochondrial DNA (mtDNA) following aging. Any impairments in oocyte mitochondrial function have negative effects on the repr...
Main Authors: | , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2019-11-01
|
Series: | Cell & Bioscience |
Subjects: | |
Online Access: | https://doi.org/10.1186/s13578-019-0360-5 |
id |
doaj-139ca914f0d8451eaf7db7d1689bbfd8 |
---|---|
record_format |
Article |
spelling |
doaj-139ca914f0d8451eaf7db7d1689bbfd82020-11-29T12:20:55ZengBMCCell & Bioscience2045-37012019-11-019111510.1186/s13578-019-0360-5Autologous mitochondrial microinjection; a strategy to improve the oocyte quality and subsequent reproductive outcome during agingHalimeh Mobarak0Mohammad Heidarpour1Pei-Shiue Jason Tsai2Aysa Rezabakhsh3Reza Rahbarghazi4Mohammad Nouri5Mahdi Mahdipour6Women’s Reproductive Health Research Center, Tabriz University of Medical SciencesDepartment of Clinical Sciences, Faculty of Veterinary Medicine, Ferdowsi University of MashhadCenter for Developmental Biology and Regenerative Medicine Research, National Taiwan University/NTUAging Research Institute, Tabriz University of Medical SciencesStem Cell Research Center, Tabriz University of Medical SciencesStem Cell Research Center, Tabriz University of Medical SciencesStem Cell Research Center, Tabriz University of Medical SciencesAbstract Along with the decline in oocyte quality, numerous defects such as mitochondrial insufficiency and the increase of mutation and deletion have been reported in oocyte mitochondrial DNA (mtDNA) following aging. Any impairments in oocyte mitochondrial function have negative effects on the reproduction and pregnancy outcome. It has been stated that infertility problems caused by poor quality oocytes in women with in vitro fertilization (IVF) and repeated pregnancy failures are associated with aging and could be overcome by transferring large amounts of healthy mitochondria. Hence, researches on biology, disease, and the therapeutic use of mitochondria continue to introduce some clinical approaches such as autologous mitochondrial transfer techniques. Following mitochondrial transfer, the amount of ATP required for aged-oocyte during fertilization, blastocyst formation, and subsequent embryonic development could be an alternative modality. These modulations improve the pregnancy outcome in women of high reproductive aging as well. In addition to overview the clinical studies using mitochondrial microinjection, this study provides a framework for future approaches to develop effective treatments and preventions of congenital transmission of mitochondrial DNA mutations/diseases to offspring. Mitochondrial transfer from ovarian cells and healthy oocytes could lead to improved fertility outcome in low-quality oocytes. The modulation of mitochondrial bioactivity seems to regulate basal metabolism inside target oocytes and thereby potentiate physiological activity of these cells while overcoming age-related infertility in female germ cells.https://doi.org/10.1186/s13578-019-0360-5Oocyte qualityMitochondrial transferAgeingReproduction |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Halimeh Mobarak Mohammad Heidarpour Pei-Shiue Jason Tsai Aysa Rezabakhsh Reza Rahbarghazi Mohammad Nouri Mahdi Mahdipour |
spellingShingle |
Halimeh Mobarak Mohammad Heidarpour Pei-Shiue Jason Tsai Aysa Rezabakhsh Reza Rahbarghazi Mohammad Nouri Mahdi Mahdipour Autologous mitochondrial microinjection; a strategy to improve the oocyte quality and subsequent reproductive outcome during aging Cell & Bioscience Oocyte quality Mitochondrial transfer Ageing Reproduction |
author_facet |
Halimeh Mobarak Mohammad Heidarpour Pei-Shiue Jason Tsai Aysa Rezabakhsh Reza Rahbarghazi Mohammad Nouri Mahdi Mahdipour |
author_sort |
Halimeh Mobarak |
title |
Autologous mitochondrial microinjection; a strategy to improve the oocyte quality and subsequent reproductive outcome during aging |
title_short |
Autologous mitochondrial microinjection; a strategy to improve the oocyte quality and subsequent reproductive outcome during aging |
title_full |
Autologous mitochondrial microinjection; a strategy to improve the oocyte quality and subsequent reproductive outcome during aging |
title_fullStr |
Autologous mitochondrial microinjection; a strategy to improve the oocyte quality and subsequent reproductive outcome during aging |
title_full_unstemmed |
Autologous mitochondrial microinjection; a strategy to improve the oocyte quality and subsequent reproductive outcome during aging |
title_sort |
autologous mitochondrial microinjection; a strategy to improve the oocyte quality and subsequent reproductive outcome during aging |
publisher |
BMC |
series |
Cell & Bioscience |
issn |
2045-3701 |
publishDate |
2019-11-01 |
description |
Abstract Along with the decline in oocyte quality, numerous defects such as mitochondrial insufficiency and the increase of mutation and deletion have been reported in oocyte mitochondrial DNA (mtDNA) following aging. Any impairments in oocyte mitochondrial function have negative effects on the reproduction and pregnancy outcome. It has been stated that infertility problems caused by poor quality oocytes in women with in vitro fertilization (IVF) and repeated pregnancy failures are associated with aging and could be overcome by transferring large amounts of healthy mitochondria. Hence, researches on biology, disease, and the therapeutic use of mitochondria continue to introduce some clinical approaches such as autologous mitochondrial transfer techniques. Following mitochondrial transfer, the amount of ATP required for aged-oocyte during fertilization, blastocyst formation, and subsequent embryonic development could be an alternative modality. These modulations improve the pregnancy outcome in women of high reproductive aging as well. In addition to overview the clinical studies using mitochondrial microinjection, this study provides a framework for future approaches to develop effective treatments and preventions of congenital transmission of mitochondrial DNA mutations/diseases to offspring. Mitochondrial transfer from ovarian cells and healthy oocytes could lead to improved fertility outcome in low-quality oocytes. The modulation of mitochondrial bioactivity seems to regulate basal metabolism inside target oocytes and thereby potentiate physiological activity of these cells while overcoming age-related infertility in female germ cells. |
topic |
Oocyte quality Mitochondrial transfer Ageing Reproduction |
url |
https://doi.org/10.1186/s13578-019-0360-5 |
work_keys_str_mv |
AT halimehmobarak autologousmitochondrialmicroinjectionastrategytoimprovetheoocytequalityandsubsequentreproductiveoutcomeduringaging AT mohammadheidarpour autologousmitochondrialmicroinjectionastrategytoimprovetheoocytequalityandsubsequentreproductiveoutcomeduringaging AT peishiuejasontsai autologousmitochondrialmicroinjectionastrategytoimprovetheoocytequalityandsubsequentreproductiveoutcomeduringaging AT aysarezabakhsh autologousmitochondrialmicroinjectionastrategytoimprovetheoocytequalityandsubsequentreproductiveoutcomeduringaging AT rezarahbarghazi autologousmitochondrialmicroinjectionastrategytoimprovetheoocytequalityandsubsequentreproductiveoutcomeduringaging AT mohammadnouri autologousmitochondrialmicroinjectionastrategytoimprovetheoocytequalityandsubsequentreproductiveoutcomeduringaging AT mahdimahdipour autologousmitochondrialmicroinjectionastrategytoimprovetheoocytequalityandsubsequentreproductiveoutcomeduringaging |
_version_ |
1724411967879249920 |